NDC 57237-274 – Lamivudine
Lamivudine 10 mg/mL · Solution · Oral
Product NDC57237-274
Product details
- Brand name
- Lamivudine
- Generic name
- Lamivudine
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- ANDA · ANDA077695
- Marketed since
- November 21, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Lamivudine 10 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 57237-274-24 | 240 mL in 1 BOTTLE (57237-274-24) | Nov 21, 2016 |
Other Lamivudine products
- 60687-720 Lamivudine 150 mg/1 · Tablet, Film Coated · American Health Packaging
- 60505-3251 Lamivudine 150 mg/1 · Tablet, Film Coated · Apotex Corp.
- 60505-3252 Lamivudine 300 mg/1 · Tablet, Film Coated · Apotex Corp.
- 60505-3250 Lamivudine 100 mg/1 · Tablet, Film Coated · Apotex Corp.
- 65862-025 Lamivudine 150 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 65862-055 Lamivudine 10 mg/mL · Solution · Aurobindo Pharma Limited
- 65862-026 Lamivudine 300 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 31722-001 Lamivudine 100 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-752 Lamivudine 100 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-753 Lamivudine 150 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-754 Lamivudine 300 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 68999-706 Lamivudine 10 mg/mL · Solution · Chartwell Govermental & Specialty RX, LLC.